Publications

Published Works

Optimal data commercialisation: transforming raw data into revenue-generating insights

Partners Zenas Choi and Cullen Taylor co-authored an article titled: "Optimal data commercialisation: transforming raw data into revenue-generating insights" published on Financier...

Hogan Lovells Publications

Digital Health: The issues you need to consider to leverage its full potential in 2018

Technology is changing the way the healthcare industry operates, bringing huge potential for untapped business opportunity. At the same time, with these changes comes a dramatic shift in...

Hogan Lovells Publications

U.S. – What does the Impression Products v. Lexmark decision mean for drug companies? 5 takeaways

Last May, the U.S. Supreme Court issued a highly-anticipated decision in Impression Products, Inc. v. Lexmark Int’l, Inc., reversing the Federal Circuit and holding that, when a...

Hogan Lovells Publications

U.S. – Protecting IP in digital health deals

Industry sources estimate that more than US$4 billion worth of deals in digital health have been signed globally this year so far, as pharmaceutical manufacturers look for "beyond the pill" ...

Hogan Lovells Publications

New FDA draft guidance on Contract Manufacturing Quality Agreements

On 28 May 2013, FDA issued a draft guidance for the industry, titled Contract Manufacturing Arrangements for Drugs: Quality Agreements. The release of this draft guidance is important...

;
Loading data